{"id": 8477, "input_str": " BOSTON \u2014 The trajectory of amyloid plaque buildup\u2014clumps of abnormal proteins in the brain linked to Alzheimer\u2019s disease\u2014may serve as a more powerful biomarker for early detection of cognitive decline rather than using the total amount to gauge risk, researchers from Penn Medicine\u2019s Department of Radiology suggest in a new study published online July 15 in Neurobiology of Aging. An abstract (#O4-07-03) on the topic was also presented July 17 at the", "correct_token_str": " 2013", "generated_token_str": " American", "generator_index": 1, "correct_logprobs": [-7.983652114868164, -5.779597759246826, -5.269742012023926], "generated_logprobs": [-5.9185919761657715, -0.7748295068740845, -1.8940632343292236], "generator_names": ["gelu_two_layers/", "gelu_twelve_layers/", "gelu_twenty_four_layers/"]}